Trials / Completed
CompletedNCT06434584
Explainable Insulin Decision-making System to Assist Physicians in Diabetes Management
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The investigators plan to conduct a multi-case, multi-reader observational study with the primary objective of exploring the effects of an interpretable insulin-assisted decision-making system on physicians' (1) decision accuracy and (2) decision confidence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | without AI assistance | provide insulin dosage and confidence score without AI assistance |
| OTHER | with AI dosage assistance | provide insulin dosage and confidence score with AI dosage assistance |
| OTHER | with explainable AI assistance | provide insulin dosage and confidence score with explainable AI assistance |
| OTHER | with faulty explainable AI assistance | provide insulin dosage and confidence score with faulty explainable AI assistance |
Timeline
- Start date
- 2022-12-10
- Primary completion
- 2023-03-20
- Completion
- 2023-06-10
- First posted
- 2024-05-30
- Last updated
- 2024-05-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06434584. Inclusion in this directory is not an endorsement.